Global Developmental Delay Clinical Trial
Official title:
Effects of Family Workshops on Children With Global Developmental Delays and Their Parents
To investigate the therapeutic effects of family workshops on children with global developmental delays and their parents by the analysis of the previously conducted workshops.
Status | Not yet recruiting |
Enrollment | 101 |
Est. completion date | August 1, 2022 |
Est. primary completion date | August 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Months to 36 Months |
Eligibility | Inclusion Criteria: - Children aged 18-36 months old with global developmental delays (language developmental delay, with motor, cognition, or social and emotional developmental delays) Parents and children attended the one 2 hour-session of workshop per week for 6 weeks Exclusion Criteria: - Less than 18 months old or older than 36 months old |
Country | Name | City | State |
---|---|---|---|
Taiwan | Shin Kong Wu Ho-Su Memorial Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pediatric Outcome Data Collection Instrument | measure the functional performance of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change of Pediatric Outcome Data Collection Instrument from baseline to 6 weeks after treatment | |
Secondary | Mandarin-Chinese Communicative Developmental Inventory | assess communication function of children, <10% indicates delayed development, 10% or more than 10% indicates normal development | percent change of Mandarin-Chinese Communicative Developmental Inventory from baseline to 6 weeks after treatment | |
Secondary | Peabody Developmental Motor Scale | assess fine motor function of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change of Peabody Developmental Motor Scale from baseline to 6 weeks after treatment | |
Secondary | Emotional Competency Rating Scale | assess the emotional function of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change of Emotional Competency Rating Scale from baseline to 6 weeks after treatment | |
Secondary | Pediatric Evaluation of Disability Inventory | assess the functional skill attainment of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change of Pediatric Evaluation of Disability Inventory from baseline to 6 weeks after treatment | |
Secondary | Pediatric Daily Occupation Scale | assess the occupational performance in the daily life of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change Pediatric Daily Occupation Scale from baseline to 6 weeks after treatment | |
Secondary | Pediatric Quality of Life Inventory-Geriatric Core Scale | assess the quality of life of children, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change ofPediatric Quality of Life Inventory-Geriatric Core Scale from baseline to 6 weeks after treatment | |
Secondary | Pediatric Quality of Life Inventory-Family Impact Module | assess the impact of pediatric conditions on family functioning and parental quality of life, the minimum and maximum values range from 1 to 100, higher scores mean a better outcome | scores change of Pediatric Quality of Life Inventory-Family Impact Module from baseline to 6 weeks after treatment | |
Secondary | Parental satisfaction questionnaire | assess the parents' satisfaction with the workshops, with scores ranging from 1-to 100, higher scores mean a higher satisfaction | scores of Parental satisfaction questionnaire after treatment | |
Secondary | Caregiver Strain Index | assess family strain, the minimum and maximum values range from 1 to 100, higher scores mean a worse outcome | scores change of Caregiver Strain Index from baseline to 6 weeks after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04511767 -
Reliability and Validity of CCISO for Diagnosis of Autism Spectrum Disorder
|
||
Completed |
NCT01430845 -
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
|
||
Completed |
NCT05408351 -
The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
|
||
Completed |
NCT01601158 -
Umbilical Cord Blood Therapy for Children With Global Developmental Delay
|
N/A | |
Completed |
NCT03847402 -
The Early Integrated Intervention for Child Brain-developmental Disorders in China
|
N/A | |
Completed |
NCT01441674 -
Animal Assisted Therapy in a Pediatric Setting
|
Phase 1/Phase 2 | |
Completed |
NCT01769716 -
Umbilical Cord Blood Therapy for Global Developmental Delay
|
N/A | |
Recruiting |
NCT05879952 -
Virtual Reality and Neuropsychiatric Rehabilitation in Patients With Global Developmental Delay.
|
N/A | |
Completed |
NCT04816175 -
Intensive Therapy for Children With Microcephaly, Hyperkinetic Movements, or Global Developmental Delay
|
N/A | |
Completed |
NCT05398900 -
Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires - Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children
|